(Q85377958)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23132702%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

title

Impact of oncology-related direct-to-consumer advertising: association with appropriate and inappropriate prescriptions (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23132702%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23132702%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

author name string

Gregory A Abel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23132702%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Nathan Taback

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23132702%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Michael J Hassett

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23132702%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Deborah Schrag

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23132702%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

Jane C Weeks

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23132702%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

publication date

6 November 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23132702%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23132702%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

volume

119

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23132702%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23132702%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

page(s)

1065-1072

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23132702%20AND%20SRC:MED&resulttype=core&format=json

Direct-to-consumer prescription drug advertising: trends, impact, and implications

17 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27814

7 January 2021

Effects of direct-to-consumer advertising of hydroxymethylglutaryl coenzyme a reductase inhibitors on attainment of LDL-C goals.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27814

7 January 2021

Factors influencing the shift of patients from one proton pump inhibitor to another: the effect of direct-to-consumer advertising

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27814

7 January 2021

Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27814

7 January 2021

Effect of illicit direct to consumer advertising on use of etanercept, mometasone, and tegaserod in Canada: controlled longitudinal study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27814

7 January 2021

Relationship between direct-to-consumer advertising and physician diagnosing and prescribing.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27814

7 January 2021

Promotion of prescription drugs to consumers.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27814

7 January 2021

American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27814

7 January 2021

Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27814

7 January 2021

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27814

7 January 2021

A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27814

7 January 2021

American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27814

7 January 2021

The demography of menopause

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27814

7 January 2021

Age at natural menopause and sociodemographic status in Finland

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27814

7 January 2021

Misclassification bias related to definition of menopausal status in case-control studies of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27814

7 January 2021

Defining menopausal status in epidemiologic studies: A comparison of multiple approaches and their effects on breast cancer rates

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27814

7 January 2021

Direct-to-consumer advertising in oncology: a content analysis of print media.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27814

7 January 2021

How direct-to-consumer television advertising for osteoarthritis drugs affects physicians' prescribing behavior

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27814

7 January 2021

Effects of pharmaceutical promotion on adherence to the treatment guidelines for depression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27814

7 January 2021

Costs and consequences of direct-to-consumer advertising for clopidogrel in Medicaid

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27814

7 January 2021

The cost-effectiveness of direct-to-consumer advertising for prescription drugs

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27814

7 January 2021

Direct-to-consumer and physician promotion of tegaserod correlated with physician visits, diagnoses, and prescriptions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27814

7 January 2021

National trends in treatment of type 2 diabetes mellitus, 1994-2007

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27814

7 January 2021

Impact of clinical trial results on national trends in alpha-blocker prescribing, 1996-2002.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27814

7 January 2021

Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27814

7 January 2021

Segmented regression analysis of interrupted time series studies in medication use research

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27814

7 January 2021

A new look at the statistical model identification

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27814

7 January 2021

Estimating the Dimension of a Model

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27814

7 January 2021

Summary of aromatase inhibitor clinical trials in postmenopausal women with early breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27814

7 January 2021

Pre-menopausal breast cancer and aromatase inhibitors: Treating a new generation of women

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27814

7 January 2021

Effects of direct-to-consumer advertising and clinical guidelines on appropriate use of human papillomavirus DNA tests

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27814

7 January 2021

Direct-to-consumer advertising of COX-2 inhibitors: effect on appropriateness of prescribing

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27814

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27814

7 January 2021

Update on Direct-to-Consumer Marketing in Oncology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27814

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27814

7 January 2021

The impact of denying a direct-to-consumer advertised drug request on the patient/physician relationship

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27814

7 January 2021

Consumers' Reports On The Health Effects Of Direct-To-Consumer Drug Advertising

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27814

7 January 2021

The role of direct-to-consumer pharmaceutical advertisements and individual differences in getting people to talk to physicians.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27814

7 January 2021

Predictors and temporal trends of adjuvant aromatase inhibitor use in breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.27814

7 January 2021

Identifiers

DOI

10.1002/CNCR.27814

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23132702%20AND%20SRC:MED&resulttype=core&format=json

17 February 2020

1 reference